BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 12099190)

  • 41. Women's knowledge and attitudes about genetic testing for breast cancer susceptibility.
    Ludman EJ; Curry SJ; Hoffman E; Taplin S
    Eff Clin Pract; 1999; 2(4):158-62. PubMed ID: 10539540
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical implications of genetic testing for inherited breast and ovarian cancer risk.
    Calzone KA
    Nurs Spectr (Wash D C); 1998 Nov; 8(23):12-4. PubMed ID: 10542772
    [No Abstract]   [Full Text] [Related]  

  • 43. The development of a cancer genetic-specific measure of coping: the GRACE.
    Phelps C; Bennett P; Jones H; Hood K; Brain K; Murray A
    Psychooncology; 2010 Aug; 19(8):847-54. PubMed ID: 19823974
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic and familial factors influencing breast, colon, prostate and lung cancers.
    Stein QP; Flanagan JD
    S D Med; 2010; Spec No():16-22. PubMed ID: 20397487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Current status and perspectives for genetic consultation and prophylactic medical examination of risk groups with malignant neoplasms of the female reproductive system and breast].
    Akulenko LV; Gar'kavtseva RF; Zhordania KI; Samgina AA
    Tsitol Genet; 1992; 26(1):38-42. PubMed ID: 1621284
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Organizing cancer genetics programs: the Swiss model.
    Pichert G; Stahel RA
    J Clin Oncol; 2000 Nov; 18(21 Suppl):65S-9S. PubMed ID: 11060330
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of a cancer risk assessment clinic.
    Med Manag Netw; 1999 Jul; 7(7):6-10. PubMed ID: 10538699
    [No Abstract]   [Full Text] [Related]  

  • 48. An interactive computer program for educating and counseling patients about genetic susceptibility to breast cancer.
    Green MJ; Fost N
    J Cancer Educ; 1997; 12(4):204-8. PubMed ID: 9440011
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Psychological distress in women seeking genetic counseling for breast-ovarian cancer risk: the contributions of personality and appraisal.
    Audrain J; Schwartz MD; Lerman C; Hughes C; Peshkin BN; Biesecker B
    Ann Behav Med; 1997; 19(4):370-7. PubMed ID: 9706364
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic evaluation of cancer: the importance of family history.
    Chew HK
    Tex Med; 2001 Feb; 97(2):40-5. PubMed ID: 11233057
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Should insurance pay for preventive services suggested by genetics?
    Lawrence J
    Manag Care; 1997 Jan; 6(1):42-6. PubMed ID: 10164532
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Psychosocial aspects of predictive gene diagnosis in familial breast and ovarian carcinomas].
    von der Groeben C; Neef K; Rohde A; Bodden-Heidrich R; Schmutzler RK
    Dtsch Med Wochenschr; 1999 Mar; 124(12):361-2. PubMed ID: 10214370
    [No Abstract]   [Full Text] [Related]  

  • 53. Women's satisfaction with genetic counseling for hereditary breast-ovarian cancer: psychological aspects.
    Tercyak KP; Demarco TA; Mars BD; Peshkin BN
    Am J Med Genet A; 2004 Nov; 131(1):36-41. PubMed ID: 15389697
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Communicating risk of hereditary breast and ovarian cancer with an interactive decision support tool.
    Rupert DJ; Squiers LB; Renaud JM; Whitehead NS; Osborn RJ; Furberg RD; Squire CM; Tzeng JP
    Patient Educ Couns; 2013 Aug; 92(2):188-96. PubMed ID: 23664232
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Should there be a breast cancer risk chart for New Zealand women?
    Richardson A; Cox B; Graham P
    N Z Med J; 1999 Apr; 112(1086):129-30. PubMed ID: 10340689
    [No Abstract]   [Full Text] [Related]  

  • 56. Hereditary breast cancer: practical pursuit for clinical translation.
    Lynch HT; Snyder C; Lynch J
    Ann Surg Oncol; 2012 Jun; 19(6):1723-31. PubMed ID: 22434244
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Experiences from a clinic for patients with hereditary cancer. Diagnosis of genetic carriers may prevent cancer].
    Lindblom A; Iselius L
    Lakartidningen; 1995 May; 92(18):1915-8. PubMed ID: 7746044
    [No Abstract]   [Full Text] [Related]  

  • 58. Knowledge and expectations of women undergoing cancer genetic risk assessment: a qualitative analysis of free-text questionnaire comments.
    Phelps C; Wood F; Bennett P; Brain K; Gray J
    J Genet Couns; 2007 Aug; 16(4):505-14. PubMed ID: 17318449
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic counselling and prophylactic surgery in women from families with hereditary breast or ovarian cancer.
    Lobb E; Meiser B
    Lancet; 2004 Jun; 363(9424):1841-2. PubMed ID: 15183619
    [No Abstract]   [Full Text] [Related]  

  • 60. [Hereditary breast and ovarian cancer - indications for genetic testing, counseling and options for mutation carriers].
    Bürki N
    Ther Umsch; 2010 Jul; 67(7):359-66. PubMed ID: 20577964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.